Cargando…

In vitro disease modeling of oculocutaneous albinism type 1 and 2 using human induced pluripotent stem cell-derived retinal pigment epithelium

Oculocutaneous albinism (OCA) encompasses a set of autosomal recessive genetic conditions that affect pigmentation in the eye, skin, and hair. OCA patients display reduced best-corrected visual acuity, reduced to absent ocular pigmentation, abnormalities in fovea development, and/or abnormal decussa...

Descripción completa

Detalles Bibliográficos
Autores principales: George, Aman, Sharma, Ruchi, Pfister, Tyler, Abu-Asab, Mones, Hotaling, Nathan, Bose, Devika, DeYoung, Charles, Chang, Justin, Adams, David R., Cogliati, Tiziana, Bharti, Kapil, Brooks, Brian P.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8758966/
https://www.ncbi.nlm.nih.gov/pubmed/35021041
http://dx.doi.org/10.1016/j.stemcr.2021.11.016
_version_ 1784633014747136000
author George, Aman
Sharma, Ruchi
Pfister, Tyler
Abu-Asab, Mones
Hotaling, Nathan
Bose, Devika
DeYoung, Charles
Chang, Justin
Adams, David R.
Cogliati, Tiziana
Bharti, Kapil
Brooks, Brian P.
author_facet George, Aman
Sharma, Ruchi
Pfister, Tyler
Abu-Asab, Mones
Hotaling, Nathan
Bose, Devika
DeYoung, Charles
Chang, Justin
Adams, David R.
Cogliati, Tiziana
Bharti, Kapil
Brooks, Brian P.
author_sort George, Aman
collection PubMed
description Oculocutaneous albinism (OCA) encompasses a set of autosomal recessive genetic conditions that affect pigmentation in the eye, skin, and hair. OCA patients display reduced best-corrected visual acuity, reduced to absent ocular pigmentation, abnormalities in fovea development, and/or abnormal decussation of optic nerve fibers. It has been hypothesized that improving eye pigmentation could prevent or rescue some of the vision defects. The goal of the present study was to develop an in vitro model for studying pigmentation defects in human retinal pigment epithelium (RPE). We developed a “disease in a dish” model for OCA1A and OCA2 types using induced pluripotent stem cells to generate RPE. The RPE is a monolayer of cells that are pigmented, polarized, and polygonal in shape, located between the neural retina and choroid, with an important role in vision. Here we show that RPE tissue derived in vitro from OCA patients recapitulates the pigmentation defects seen in albinism, while retaining the apical-basal polarity and normal polygonal morphology of the constituent RPE cells.
format Online
Article
Text
id pubmed-8758966
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Elsevier
record_format MEDLINE/PubMed
spelling pubmed-87589662022-01-19 In vitro disease modeling of oculocutaneous albinism type 1 and 2 using human induced pluripotent stem cell-derived retinal pigment epithelium George, Aman Sharma, Ruchi Pfister, Tyler Abu-Asab, Mones Hotaling, Nathan Bose, Devika DeYoung, Charles Chang, Justin Adams, David R. Cogliati, Tiziana Bharti, Kapil Brooks, Brian P. Stem Cell Reports Resource Oculocutaneous albinism (OCA) encompasses a set of autosomal recessive genetic conditions that affect pigmentation in the eye, skin, and hair. OCA patients display reduced best-corrected visual acuity, reduced to absent ocular pigmentation, abnormalities in fovea development, and/or abnormal decussation of optic nerve fibers. It has been hypothesized that improving eye pigmentation could prevent or rescue some of the vision defects. The goal of the present study was to develop an in vitro model for studying pigmentation defects in human retinal pigment epithelium (RPE). We developed a “disease in a dish” model for OCA1A and OCA2 types using induced pluripotent stem cells to generate RPE. The RPE is a monolayer of cells that are pigmented, polarized, and polygonal in shape, located between the neural retina and choroid, with an important role in vision. Here we show that RPE tissue derived in vitro from OCA patients recapitulates the pigmentation defects seen in albinism, while retaining the apical-basal polarity and normal polygonal morphology of the constituent RPE cells. Elsevier 2022-01-11 /pmc/articles/PMC8758966/ /pubmed/35021041 http://dx.doi.org/10.1016/j.stemcr.2021.11.016 Text en © 2021. https://creativecommons.org/licenses/by-nc-nd/3.0/igo/This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/3.0/igo/).
spellingShingle Resource
George, Aman
Sharma, Ruchi
Pfister, Tyler
Abu-Asab, Mones
Hotaling, Nathan
Bose, Devika
DeYoung, Charles
Chang, Justin
Adams, David R.
Cogliati, Tiziana
Bharti, Kapil
Brooks, Brian P.
In vitro disease modeling of oculocutaneous albinism type 1 and 2 using human induced pluripotent stem cell-derived retinal pigment epithelium
title In vitro disease modeling of oculocutaneous albinism type 1 and 2 using human induced pluripotent stem cell-derived retinal pigment epithelium
title_full In vitro disease modeling of oculocutaneous albinism type 1 and 2 using human induced pluripotent stem cell-derived retinal pigment epithelium
title_fullStr In vitro disease modeling of oculocutaneous albinism type 1 and 2 using human induced pluripotent stem cell-derived retinal pigment epithelium
title_full_unstemmed In vitro disease modeling of oculocutaneous albinism type 1 and 2 using human induced pluripotent stem cell-derived retinal pigment epithelium
title_short In vitro disease modeling of oculocutaneous albinism type 1 and 2 using human induced pluripotent stem cell-derived retinal pigment epithelium
title_sort in vitro disease modeling of oculocutaneous albinism type 1 and 2 using human induced pluripotent stem cell-derived retinal pigment epithelium
topic Resource
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8758966/
https://www.ncbi.nlm.nih.gov/pubmed/35021041
http://dx.doi.org/10.1016/j.stemcr.2021.11.016
work_keys_str_mv AT georgeaman invitrodiseasemodelingofoculocutaneousalbinismtype1and2usinghumaninducedpluripotentstemcellderivedretinalpigmentepithelium
AT sharmaruchi invitrodiseasemodelingofoculocutaneousalbinismtype1and2usinghumaninducedpluripotentstemcellderivedretinalpigmentepithelium
AT pfistertyler invitrodiseasemodelingofoculocutaneousalbinismtype1and2usinghumaninducedpluripotentstemcellderivedretinalpigmentepithelium
AT abuasabmones invitrodiseasemodelingofoculocutaneousalbinismtype1and2usinghumaninducedpluripotentstemcellderivedretinalpigmentepithelium
AT hotalingnathan invitrodiseasemodelingofoculocutaneousalbinismtype1and2usinghumaninducedpluripotentstemcellderivedretinalpigmentepithelium
AT bosedevika invitrodiseasemodelingofoculocutaneousalbinismtype1and2usinghumaninducedpluripotentstemcellderivedretinalpigmentepithelium
AT deyoungcharles invitrodiseasemodelingofoculocutaneousalbinismtype1and2usinghumaninducedpluripotentstemcellderivedretinalpigmentepithelium
AT changjustin invitrodiseasemodelingofoculocutaneousalbinismtype1and2usinghumaninducedpluripotentstemcellderivedretinalpigmentepithelium
AT adamsdavidr invitrodiseasemodelingofoculocutaneousalbinismtype1and2usinghumaninducedpluripotentstemcellderivedretinalpigmentepithelium
AT cogliatitiziana invitrodiseasemodelingofoculocutaneousalbinismtype1and2usinghumaninducedpluripotentstemcellderivedretinalpigmentepithelium
AT bhartikapil invitrodiseasemodelingofoculocutaneousalbinismtype1and2usinghumaninducedpluripotentstemcellderivedretinalpigmentepithelium
AT brooksbrianp invitrodiseasemodelingofoculocutaneousalbinismtype1and2usinghumaninducedpluripotentstemcellderivedretinalpigmentepithelium